Literature DB >> 22642628

Macrophages, atherosclerosis and the potential of netrin-1 as a novel target for future therapeutic intervention.

Kathryn J Moore, Edward A Fisher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22642628      PMCID： PMC3920546          DOI： 10.2217/fca.12.30

Source DB:  PubMed          Journal:  Future Cardiol        ISSN： 1479-6678


× No keyword cloud information.
  20 in total

Review 1.  The in and out of monocytes in atherosclerotic plaques: Balancing inflammation through migration.

Authors:  Burkhard Ludewig; Jon D Laman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-03       Impact factor: 11.205

2.  Netrin-1 inhibits leukocyte migration in vitro and in vivo.

Authors:  Ngoc P Ly; Katsumi Komatsuzaki; Iain P Fraser; Anita A Tseng; Parthak Prodhan; Kathryn J Moore; T Bernard Kinane
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

3.  Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.

Authors:  Katey J Rayner; Frederick J Sheedy; Christine C Esau; Farah N Hussain; Ryan E Temel; Saj Parathath; Janine M van Gils; Alistair J Rayner; Aaron N Chang; Yajaira Suarez; Carlos Fernandez-Hernando; Edward A Fisher; Kathryn J Moore
Journal:  J Clin Invest       Date:  2011-06-06       Impact factor: 14.808

4.  The role of the monocyte in atherogenesis: II. Migration of foam cells from atherosclerotic lesions.

Authors:  R G Gerrity
Journal:  Am J Pathol       Date:  1981-05       Impact factor: 4.307

5.  Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E-deficient mouse in a novel transplantation model.

Authors:  E D Reis; J Li; Z A Fayad; J X Rong; D Hansoty; J G Aguinaldo; J T Fallon; E A Fisher
Journal:  J Vasc Surg       Date:  2001-09       Impact factor: 4.268

6.  Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regression.

Authors:  Stephane Potteaux; Emmanuel L Gautier; Susan B Hutchison; Nico van Rooijen; Daniel J Rader; Michael J Thomas; Mary G Sorci-Thomas; Gwendalyn J Randolph
Journal:  J Clin Invest       Date:  2011-04-18       Impact factor: 14.808

Review 7.  Macrophages in the pathogenesis of atherosclerosis.

Authors:  Kathryn J Moore; Ira Tabas
Journal:  Cell       Date:  2011-04-29       Impact factor: 41.582

8.  NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals.

Authors:  Peter Duewell; Hajime Kono; Katey J Rayner; Cherilyn M Sirois; Gregory Vladimer; Franz G Bauernfeind; George S Abela; Luigi Franchi; Gabriel Nuñez; Max Schnurr; Terje Espevik; Egil Lien; Katherine A Fitzgerald; Kenneth L Rock; Kathryn J Moore; Samuel D Wright; Veit Hornung; Eicke Latz
Journal:  Nature       Date:  2010-04-29       Impact factor: 49.962

9.  Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques.

Authors:  Jaime Llodrá; Véronique Angeli; Jianhua Liu; Eugene Trogan; Edward A Fisher; Gwendalyn J Randolph
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-27       Impact factor: 11.205

10.  The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques.

Authors:  Janine M van Gils; Merran C Derby; Luciana R Fernandes; Bhama Ramkhelawon; Tathagat D Ray; Katey J Rayner; Sajesh Parathath; Emilie Distel; Jessica L Feig; Jacqueline I Alvarez-Leite; Alistair J Rayner; Thomas O McDonald; Kevin D O'Brien; Lynda M Stuart; Edward A Fisher; Adam Lacy-Hulbert; Kathryn J Moore
Journal:  Nat Immunol       Date:  2012-01-08       Impact factor: 25.606
View more
  4 in total

Review 1.  Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2013-10-21

2.  Netrin-1 and its receptor Unc5b are novel targets for the treatment of inflammatory arthritis.

Authors:  Aránzazu Mediero; Tuere Wilder; Bhama Ramkhelawon; Kathryn J Moore; Bruce N Cronstein
Journal:  FASEB J       Date:  2016-08-08       Impact factor: 5.191

3.  The effect of prebiotic supplementation with inulin on cardiometabolic health: Rationale, design, and methods of a controlled feeding efficacy trial in adults at risk of type 2 diabetes.

Authors:  Cassie M Mitchell; Brenda M Davy; Tanya M Halliday; Mathew W Hulver; Andrew P Neilson; Monica A Ponder; Kevin P Davy
Journal:  Contemp Clin Trials       Date:  2015-10-28       Impact factor: 2.226

4.  Evaluation of Netrin-1 Levels and Albuminuria in Patients With Diabetes.

Authors:  Emre Ay; Kamile Marakoğlu; Muhammet Kizmaz; Ali Ünlü
Journal:  J Clin Lab Anal       Date:  2016-04-13       Impact factor: 2.352
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.